Compare Sanofi SA (SNY) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Seagate Technology Holdings PLC — how do they compare? Sanofi SA trades at $42.95 (market cap $103.41B), while Seagate Technology Holdings PLC trades at $876 (market cap $201.45B). The key difference: Seagate Technology Holdings PLC is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.65%). Which is the better fit depends on your goals.
| SNY | STX | |
|---|---|---|
Market Cap | $103.41B | $201.45B |
Sector | Health | Technology |
52-Week High | $52.34 | $1.09K |
52-Week Low | $41.33 | $193.04 |
Enterprise Value | $123.44B | $203.61B |
Dividend Yield | 5.65% | 0.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
STX trades at $904.38, up 6.49% in 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust profitability with a net income margin of 26.11% and high ROE of 371.53%, though valuation ratios like P/E of 65.06 appear elevated. Recent news highlights AI-driven storage demand and HAMR technology advancements fueling growth, with revenue projected to rise to $12.2B in 2026.
Outlook is positive due to AI infrastructure demand and earnings momentum, but risks include high debt levels and valuation concerns. Analysts are bullish with a consensus price target of $1,130, suggesting upside potential, though investors should monitor execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
